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Staphylococcus aureus, among hospital patients as well as in the
community are threatening public health worldwide. The
capability to acquire antibiotic resistance and a plethora of
virulence factors make S. aureus formidably apt to cause disease
in these different settings. This is underscored by the large
number of different S. aureus types encountered in many hosts
and environments [1–6].
Epidemiological and, more recently, molecular studies have
shown that certain clones of S. aureus attain a geo-spatial pre-
dominance [1–6]. Importantly, various community-associated
methicillin-resistant S. aureus (CA-MRSA) clones have evolved
independently on different continents. Multilocus sequence
type (MLST/ST) 80 is the predominant CA-MRSA clone in
Europe, ST93 in Australia, ST30 in Oceania, ST8 in the United
States of America (USA), and ST59 in Asia. Nevertheless, the
exchange of clones between countries and continents has been
observed [3,4,7,8,9], as can be expected from the current
reach, volume and speed of travel [10].
The ST59 clone, which is the founder of the MLST clonal
complex 59 (CC59), is one of the most frequent multidrug
resistant CA-MRSA clones in Asia [8]. In 2007, Tristan and
colleagues reported for the ﬁrst time Asian S. aureus ST59
isolates in association with the spa type t437 [11]. Subsequently,
a large community and hospital study across Asia described the
CC59 as the most prevalent CC, including ST59 and its variants
ST1241 and ST338; moreover, ST59-MRSA-t437 was identiﬁed
as the most prevalent clone between 2004 and 2006 [8]. In the
study by Song et al., the collected CA- and hospital-associated
MRSA CC59 isolates from Asia showed rapid spread between
hospitals and the community in a bi-directional manner, and
also across borders [8]. A similar picture emerged from other
studies in Asia and Western Australia where ST59-MRSA-t437
was identiﬁed as a major clone [12–16]. In contrast, S. aureus
CC59 isolates were incidentally reported in the USA [17] and
in Europe [18–22].
Recently, a study from Belgium identiﬁed four (1%) ST338-
t437 CA-MRSA isolates amongst 410 MRSA isolates collected
between 2005 and 2009 [23]. Furthermore, a multicentre study
performed in the 16 most populous European countries iden-
tiﬁed a total number of 22 (6%) S. aureus CC59 isolates with the
spa type t437 of which one (4.5%) was methicillin-sensitive
S. aureus (MSSA) [24]. Intriguingly, Rolo and co-workers re-
ported an increased frequency of the ST59 clone since 2007, and
they concluded that this clone was most prevalent in Northern
Europe (Finland, Sweden and Poland) [24]. This is in line with
our own observations that the numbers of S. aureus t437 isolatesClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectin Norway, Denmark and Poland are increasing. Speciﬁcally, in
Norway S. aureus t437 is among the most commonly identiﬁed
MRSA clones corresponding to ~2.5% of all MRSA isolates every
year since 2008 (L. Marstein, personal communication). In
Denmark, the numbers of S. aureus t437 isolates have gone up
from zero before 2006, through 1–3 cases per year between
2006 and 2008, to 7–14 cases per year since 2007 (H. Westh,
personal communication). Lastly, the ST338-t437 PVL-positive
clone seems currently to be the most prevalent CA-MRSA clone
in Poland (J. Empel, personal communication).
Altogether, the combined literature data for Asia and
Europe, and the apparently increasing numbers of S. aureus t437
isolates in Northern Europe formed the incentive to assess the
presence of S. aureus t437 in other European countries and,
more importantly, to determine their genetic relatedness.
Clearly, the perceived risk for dissemination and establishment
of a new community-associated S. aureus clone with a multidrug
resistant phenotype in Europe would justify appropriate pre-
ventive infection control measures.Materials and methodsBacterial isolates
A total of 163 S. aureus isolates (147 from Europe and 16 from
China) with the spa type t437, collected between 2002 and
2012 from patients and healthy carriers in 11 different Euro-
pean countries and four different geographical locations in
China (i.e. Hangzhou, Zhejiang Province; Hefei, Anhui Province;
Harbin, Heilongjiang Province; and Beijing), were analysed in
the present study. The epidemiological and molecular charac-
teristics of the isolates, including origin, year of isolation, anti-
biotic phenotype and information on the patients are presented
in Appendix Table A1 in the supporting information. One
isolate from the Czech Republic with an unrelated spa type
t442 was also included in the present study.
Antibiotic susceptibility and presence of mecA and the
PVL locus
Antibiotic susceptibility for benzylpenicillin, chloramphenicol,
ciproﬂoxacin, clindamycin (constitutive), erythromycin, fosfo-
mycin, fusidic acid, gentamicin, kanamycin, linezolid, mupirocin,
oxacillin, rifampicin, teicoplanin, tetracycline, tobramycin,
trimethoprim/sulfamethoxazole and vancomycin was deter-
mined with the VITEK 2 system (AST P633 card, bioMérieux,
Marcy l’Etoil, France). The VITEK 2 minimum inhibitory con-
centration results were interpreted using the Advanced Expert
System following EUCAST guidelines (www.eucast.org). The
presence of the mecA and PVL-encoding genes (lukF-PV and lukS-
PV) was determined by PCR [25].ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 163.e1–163.e8
CMI Glasner et al. Staphylococcus aureus spa type t437 163.e3Extraction of total DNA for typing
Total DNA for the multiple-locus variable number tandem
repeat ﬁngerprinting (MLVF) typing was prepared as previously
described [2]. The preparation of lysates for multiple locus
variable number tandem repeat analysis (MLVA) and spa typing
was performed as described by Schouls et al. [25].
spa typing
The spa typing was performed according to the protocol pre-
viously described [26]. The spa types were assigned through the
use of Ridom StaphType software version 2.2.1 (Ridom GmbH,
Münster, Germany) and the SpaServer (http://www.spaserver.
ridom.de).
Multiple-locus variable number tandem repeat
ﬁngerprinting
MLVF was performed as described by Glasner et al. and Sabat
et al. using the Bioanalyzer 2100 (Agilent Technologies, Santa
Clara, CA, USA) to separate PCR fragments [2,27]. For the
analysis of electropherograms with Gel Compar II (Applied
Maths, Kortrijk, Belgium), the position tolerance and optimi-
zation were set to 0.5% and 0.5%, respectively, and the dice
formula was used to calculate the pairwise similarity coefﬁcient.
With the selected position tolerance, all Bioanalyzer runs for
the control isolate M2 (clustering together at the bottom part
of the MLVF dendrogram) were identical [27]. A dendrogram
was created with the unweighted pair-group method using
geometric averages (UPGMA).
Multiple-locus variable number tandem repeat analysis
MLVA was performed according to Schouls et al. [25]. Isolates
that differed by one or more alleles were considered distinct
types. Minimum spanning tree analysis of MLVA was performed
using BioNumerics software (Applied Maths, Kortrijk, Belgium)
to group related MLVA types (MTs) into MLVA complexes
(MCs). Such MCs encompass single locus variants as described
by Schouls et al. [25]. A singleton was deﬁned as an MT that was
not grouped into an MC.
Multilocus sequence typing
MLST was performed on representative S. aureus t437 isolates
of each MT as described by Enright et al. [28]. In brief, the allelic
proﬁles of each selected isolate were obtained by sequencing
internal fragments of seven housekeeping genes (arcC, aroE,
glpF, gmk, pta, tpi, yqiL) and entering them on the MLST
homepage (http://saureus.mlst.net), where seven numbers
depicting the allelic proﬁle were assigned that deﬁned a ST [28].
The allelic proﬁles of the S. aureus t437 isolates were compared
by using the based upon related sequence types (BURST)
program [4].Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InResultsCollection of S. aureus t437 isolates from Europe and
China
To explore the presence and genetic relatedness of S. aureus
t437 across Europe, a convenience sample of 147 isolates with
the spa type t437 was established at the Medical Microbiology
Department at the University Medical Center Groningen
(UMCG, The Netherlands). This was achieved through the
identiﬁcation of S. aureus spa type t437 isolates by inspection of
the RIDOM spa server database (www.spaserver.ridom.de). In
addition, representatives from all staphylococcal expert and
reference laboratories were approached and asked for S. aureus
spa type t437 isolates. All S. aureus isolates were then sent to
the UMCG, stored and subsequently propagated for subse-
quent molecular analyses. The spa type t437 is currently ranked
24th on the RIDOM spa server with a frequency of 0.63% and a
total number of 1878 isolates (June 2014). The collected
S. aureus t437 isolates were from 11 European countries,
namely the Netherlands (n = 64), Scotland (n = 27), Norway
(n = 20), Germany (n = 13), Denmark (n = 10), Spain (n = 3),
Poland (n = 3), France (n = 3), Sweden (n = 2), Czech Republic
(n = 1) and Hungary (n = 1). Sixteen S. aureus isolates with the
spa type t437 from patients and healthy carriers from China
that were available during the time of investigation at our
institute were added to the collection. One isolate from the
Czech Republic was originally submitted as S. aureus spa type
t437 but, during the course of investigation, it was determined
to have the unrelated spa type t442. Seventy-eight (47.9%)
S. aureus t437 isolates were sampled from abscesses and skin
infections, and 56 (34.3%) were isolated from blood or the
nose, ear or throat (supporting information Appendix
Table A1). The source of isolation is unknown for the
remaining 29 (17.8%) S. aureus t437 isolates.
Antibiotic resistance and proportion of pvl and mecA
Antibiotic susceptibility testing showed that the antibiotic
proﬁles of the 143 (87.7%) MRSA t437 isolates were very
similar to those of the 20 (12.3%) MSSA t437 isolates (Table 1).
Consistent distinctions in the resistance of the investigated
MRSA t437 and MSSA t437 isolates were only observed for
oxacillin and chloramphenicol. The increased chloramphenicol
resistance of the collected MRSA t437 isolates is in accordance
with results from Asian CA-MRSA studies [7,15]. The majority
of the investigated t437 isolates were resistant to clindamycin
(constitutive), erythromycin, kanamycin and penicillin, and all
t437 isolates were susceptible to fosfomycin, fusidic acid, line-
zolid, mupirocin, rifampicin, teicoplanin and vancomycin
(Table 1). No clear association between countries of origin orfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 163.e1–163.e8
TABLE 1. Antibiotic resistance proﬁles of the 143 MRSA t437
and 20 MSSA t437 isolates*
Antibiotic
MRSA MSSA
n (resistance rate, %) n (resistance rate, %)
Ciproﬂoxacin 2 (1.4) 2 (10)
Chloramphenicol 93 (65) 3 (15)
Clindamycin (constitutive) 118 (82.5) 17 (85)
Erythromycin 121 (84.6) 17 (85)
Fosfomycin 0 (0) 0 (0)
Fusidic acid 0 (0) 0 (0)
Gentamicin 3 (2.1) 2 (10)
Kanamycin 120 (83.9) 16 (80)
Linezolid 0 (0) 0 (0)
Mupirocin 0 (0) 0 (0)
Oxacillin 143 (100) 0 (0)
Penicillin 143 (100) 18 (90)
Rifampicin 0 (0) 0 (0)
Teicoplanin 0 (0) 0 (0)
Tetracycline 102 (71.3) 11 (55)
Tobramycin 3 (2.1) 2 (10)
Trimethoprim/sulfamethoxazole 1 (0.7) 5 (25)
Vancomycin 0 (0) 0 (0)
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive
S. aureus.
*For details on the antibiotic resistances of the study isolates, please see supporting
information Appendix Table A1.
163.e4 Clinical Microbiology and Infection, Volume 21 Number 2, February 2015 CMIsample source and a certain antibiotic resistance proﬁle could
be detected. In accordance with the observed oxacillin resis-
tance proﬁles, 88% of the isolates tested positive for mecA (143
isolates). Furthermore, 82% (134 isolates) tested positive for
the Panton-Valentine leukocidin (PVL) locus [3]. The majority
of S. aureus t437 isolates were thus both mecA- and pvl-positive
(127 isolates, 78%), as previously reported for Asian CC59
isolates [12,15]. Fifteen isolates were mecA-positive and pvl-
negative, while 21 isolates were mecA-negative of which 8 were
pvl-positive and 13 pvl-negative.
MLVF
MLVF analysis identiﬁed 37 different banding patterns among the
163 S. aureus t437 isolates as shown in Fig. 1. Sixteen patterns
were represented by two or more isolates (142 isolates in to-
tal). The remaining 21 patterns each consisted of a single isolate.
Application of previously published cut-off values of 64%, 67%
or 75% led to 2, 2 and 9 clusters, respectively [2,27]. The two
lower cut-off values joined 161 and 154 isolates into one major
cluster respectively, indicating a high genomic relatedness of
these isolates. Even without the application of a cut-off value
resulting in MLVF clusters, the relatedness of all S. aureus t437
isolates can be inferred by inspection from the highly similar
MLVF banding patterns (see also [2,27]). Slight differences in the
band sizes indicate loss or gain of repeats in the respective
variable number of tandem repeats (VNTRs). As expected, the
isolate with the unrelated spa type t442 displayed a different
MLVF pattern with only 34% similarity to the closest related
isolate in the MLVF dendrogram (Fig. 1). The MLVF patterns did
not unveil any epidemiological signal, such as the country ofClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectorigin, year of isolation or source. Thus isolates from different
countries, even from China, appeared randomly distributed
over the MLVF dendrogram. Notably, MLVF is a highly
discriminatory but non-portable PCR-based DNA ﬁngerprinting
method that utilizes size differences in ﬁve coding regions (spa,
sspA, sdrCDE, clfA and clfB) containing VNTRs. In contrast, the
subsequently implemented MLVA method for DNA typing is
suitable for inter-laboratory comparisons and allows the
determination of clonal relationships between isolates. To this
end, MLVA targets ten non-coding loci, which are sequenced
and for which the exact numbers of repeat units are measured.
This approach is therefore more precise than the visualization
of MLVF results on agarose gels or microﬂuidic chips.
MLVA
The 163 S. aureus t437 isolates produced 13 different MTs,
namely MT621, MT1035, MT1297, MT1831, MT1870, MT1875,
MT2075, MT2322, MT3560, MT4124, MT4125, MT4126 and
MT4183 (Fig. 2A and supporting information Appendix
Table A1). The MT621 was clearly the most predominant
type in the present collection comprising 133 (82%) isolates
and, more importantly, 159 (98%) S. aureus isolates belonged to
the same MC0621, comprising 9 different MTs (Fig. 2A). The
remaining four isolates were MLVA singletons (MCnone).
Generally, six MTs were shared by 2 or more isolates (156
isolates in total), whereas 7 MTs were represented by single
isolates. The included t422 isolate from the Czech Republic
belonged to the unrelated MT165 and MC5.
MLST
A total of 46 representative S. aureus t437 isolates comprising
one MT each were selected for MLST analysis (Fig. 2B). This
showed that 39 (85%) of these isolates belonged to the CC59.
ST59 was the predominant ST with 26 (57%) isolates, and the
two single-locus variants ST87 and ST338 were identiﬁed 2
(4%) and 11 (24%) times, respectively. The remaining 7 isolates,
which were all from China, belonged to ST2147 differing from
ST59 by three alleles. The included isolate with the spa-type
t422 belonged to the unrelated ST5. The relationship between
the MLST and MLVA data is depicted in Fig. 2B. The MLST
minimum spanning tree shows that ST59, the founder of CC59,
is composed of 10 different MTs.DiscussionThe present study underpins the view that the S. aureus ST59
clone and other STs of CC59 with the spa type t437 which are
commonly encountered in Asia, are present in several European
countries. More importantly, by implementing three differentious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 163.e1–163.e8
FIG. 1. MLVF dendrogram of the 163 investigated S. aureus t437 isolates generated by the UPGMA algorithm. In addition to the study isolates, one
isolate with a different spa type (t442), MLVA type and MLST type, and 16 controls (designated M2) were included in the analysis. Details on the
different isolates from top to bottom are provided in the same order in Appendix Table A1 in the supporting information. MVLA, multiple-locus
variable number tandem repeat analysis; MLST, multilocus sequence typing; MLVF, multiple locus variable number tandem repeat ﬁngerprinting;
UPGMA, unweighted pair-group method using geometric averages. *Lanes corresponding to Chinese t437 isolates.
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FIG. 2. (A) Minimum spanning tree of the 163 S. aureus t437 isolates typed by MLVA. Clustering of MLVA proﬁles was performed with a categorical
coefﬁcient. In the minimum spanning tree, the MLVA types are displayed as circles labelled with different colours. The size of each circle indicates the
number of isolates of the particular MLVA type. MLVA complexes were assigned if two neighbouring types did not differ in more than one VNTR locus.
MLVA types and complexes are indicated in characters, e.g. 621 denotes MLVA type 621, and MC0621 denotes MLVA complex 621. The three MTs
1870, 4125 and 4126 are double-locus variants of MT0621 and do not belong to any MC (MCnone). The t442 isolate from the Czech Republic is also
included in the minimum spanning tree, showing that it belongs to the unrelated MT165. (B) MLST analysis of 46 representative S. aureus t437 isolates
with BURST identiﬁes one MLST CC59, which includes ST59 (26), ST338 (10) and ST87 (2). The two other identiﬁed STs, ST2147 (7) and ST5 (one
isolate from the Czech Republic with spa type t442) are singletons. The colours within each ST circle indicate the different MTs belonging to the
respective ST. MLST, multilocus sequence typing; MLVA, multiple-locus variable number tandem repeat analysis; MT, MVLA types; ST, sequence typing;
VNTR, variable number of tandem repeats.
163.e6 Clinical Microbiology and Infection, Volume 21 Number 2, February 2015 CMIhighly discriminatory molecular typing tools, namely MLVF,
MLVA and MLST, we demonstrate a high degree of molecular
similarity in the studied S. aureus t437 isolates that were collected
over a period of 10 years from 11 different European countries.
This shows that this speciﬁc S. aureus clone is not restricted to
particular geographical regions or speciﬁc host environments,
and that S. aureus t437 in Europe belongs to a very tight mo-
lecular cluster of S. aureus isolates. The European S. aureus t437
isolates thus bear the general hallmarks of a high-risk clone.
At least 35 (21.5%) of the patients from whom the currently
investigated European S. aureus t437 isolates had been collected
were immigrants or adopted children, or had travelled to
countries outside Europe, Asia in particular (supportingClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectinformation Appendix Table A1; note that for 104 isolates no
such information could be retrieved). Such patients may have
introduced the CC59 clone in Europe and subsequently trans-
mitted it to other European citizens, including their family
members, as can be inferred from the analysis of the isolates
from the Netherlands and Denmark (supporting information
Appendix Table A1). This view is also supported by the high
genetic relatedness of the European isolates with the 16 Chinese
S. aureus t437 isolates included in our study as shown by MLVF
and MLVA. Although seven Chinese isolates belonged to ST2147
(a triple-locus variant of ST59) and only one isolate belonged
ST59, the Chinese isolates clustered among all other S. aureus
t437 isolates in the MLVF dendrogram (Fig. 1 and supportingious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 163.e1–163.e8
CMI Glasner et al. Staphylococcus aureus spa type t437 163.e7information Appendix Table A1), and 15 of these isolates
belonged to the MC0621 which includes 98% of the 163 inves-
tigated S. aureus t437 isolates. Notably, in most Asian studies
only MRSA isolates were collected and typed. It is therefore
conceivable that MSSA with the spa-type t437 belonging to
CC59 has thus far been overlooked in Asia. In contrast, the
present European S. aureus t437 isolates also include MSSA
isolates. This observation is in line with the ﬁndings reported by
Rolo et al. [24]. Otherwise, the antibiotic resistance proﬁles of
the presently investigated European S. aureus t437 isolates were
very similar to those described for Asian CC59 isolates, but not
to those of other CA S. aureus clones from Europe
[3,8,14,29,30]. Lastly, the frequency of the PVL-encoding genes
(82%) in the present S. aureus t437 sample is in accordance with
the reported numbers in the Asian studies [12,15,31].
In conclusion, we have combined MLVF, MLVA and MLST to
obtain a high-resolution snapshot of the S. aureus t437 popu-
lation in Europe based on retrospectively collected isolates that
had already been spa typed. Since spa typing or any of the three
other molecular typing methods implemented in the present
study are not yet performed on a daily routine basis in most
local laboratories and hospitals, we consider it likely that the
CC59 clone has so far remained under-detected in Europe.
This is a cause for concern in view of the predominance of
S. aureus CC59 in Asia and its clinical repercussions, in
particular multi-drug resistant soft tissue and skin infections,
even though the prevalence of CC59 in Europe is probably still
relatively low. Where possible, the further dissemination of this
potentially high-risk clone should therefore be prevented, for
example through active screening of patients with staphylo-
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